An observational study in Congenital Heart Disease in Children, sponsored by Charite University, Berlin, Germany. Completed at 1 site in Germany. Open to participants aged Up to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-29.
Sponsored by Charite University, Berlin, Germany · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 38 studies in Heart Defects, Congenital with a site in Germany — 15 open to participants now, 15 under way, none of them phase 3. Heart Defects, Congenital · Germany.
Among the 38 studies in Heart Defects, Congenital with a site in Germany, this one is the 9th largest by enrollment of the 14 observational ones that give a count, is one of 3 that started in 2025, is one of 14 observational ones, and was the 34th registered.
992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.
Browse Heart Defects, Congenital studies →15 of the 38 studies in Heart Defects, Congenital with a site in Germany are open now. Recruiting first, the newest first:
Alexandra Miriam Kiess · Sites in Germany
Ages 6–18
University Hospital Tuebingen · Sites in Germany
Charite University, Berlin, Germany · Sites in Germany
Ages 0–18
Fondation Hôpital Saint-Joseph · Sites in Germany, Denmark, Egypt and 14 more countries
Ages 1 mo+
Deutsches Herzzentrum Muenchen · Sites in Germany
Ages 8–14
A study can be open while its sites in Germany have not opened yet or have stopped. Only those recruiting at a site in Germany →
Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.
This study: Up to 18 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 5 · Phase 3 4 · Phase 4 1
First in 2003; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 200 is above the median of 119 across 440 observational studies indexed under Heart Defects, Congenital.
Median enrollment 70 across the 24 interventional studies, 300 across the 14 observational. Of the 19 that completed or were terminated, 4 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
8 of 38 have an industry lead sponsor. The 10 most frequent:
Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.
Charite University, Berlin, Germany has 5 studies filed under Heart Defects, Congenital — fewer than ten, so there is no comparison to draw.
4 of the studies in Heart Defects, Congenital with a site in Germany that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06823635Fondation Hôpital Saint-JosephAn International Multicenter Study on Transcatheter Device Closure of Perimembranous Ventricular Septal Defects | 2026-12-31 |
| NCT07716488Alexandra Miriam KiessScreening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic Disorders | 2027-01-31 |
| NCT06845371University Hospital TuebingenMELODY Registry Follow-Up Study | 2027-05-01 |
| NCT07193719Charite University, Berlin, GermanyInfluence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children | 2027-05-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 38 studies in Heart Defects, Congenital with a site in Germany, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Children undergoing cardiac surgery or cardiac catheterization often experience significant stress and anxiety during the preoperative period. A prospective, observational assessment of the preoperative/ preinterventional phase in 100 children undergoing cardiac surgery or cardiac catheterization at the Deutsches Herzzentrum der Charité demonstrated a considerable proportion of pediatric patients present with clinically relevant levels of anxiety before these procedures. Several aspects of the preoperative workflow were identified as potentially modifiable to improve the preparation of children and their families.
Based on these findings, changes in clinical practice were implemented. These measures aim to create a more supportive environment for children undergoing cardiac interventions or surgery.
The investigators now aim to re-evaluate the current preoperative preparation process for children undergoing cardiac surgery or cardiac catheterization at the Deutsches Herzzentrum der Charité and to assess its impact on preoperative stress and anxiety levels. Another 100 children will be enrolled for this follow-up assessment (100 children assessed at baseline in 2025, 100 children to be assessed in 2026, starting end of January 2026). Anxiety and stress and other patient reported outcome and experience measures as well as procedural and clinical data are assessed using validated questionnaires and CRFs prior to the procedure. The perspectives of parents or legal guardians and members of the clinical care team will also be considered to provide a comprehensive view of the preoperative experience.
992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.
This study's enrollment of 200 is above the median of 119 across 440 observational studies indexed under Heart Defects, Congenital.
Browse Heart Defects, Congenital studies →Charite University, Berlin, Germany is the lead sponsor of 857 studies on the registry; 128 are open to participants now.
Compared within Heart Defects, Congenital, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Children undergoing cardiac surgery or cardiac catheterization.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
100 children assessed in 2025
100 children to be assessed in 2026
Parental Separation Anxiety Scale
PSAS; Preoperative anxiety level; scale from 1 (not anxious) to 4 (crying, fighting) plus necessity to administer propofol for separation
Time frame: At handover from ward to anaesthesia-/ cathlab-team
University of Michigan Sedation Score
UMSS, 5 point score from awake (0) to unarousable (4)
Time frame: At handover from ward to anaesthesia-/ cathlab-team
Modified Yale Preoperative Anxiety Scale - Short Form
mYPAS-SF; Score across 4 categories, 100 is maximum, 22.9 is minimum, higher scores represent worse measures
Time frame: at handover from ward to anaesthesia or cathlab-team
Faces scale
Faces scale (pictures of different faces) for children to express how they feel
Time frame: At handover from ward to anaesthesia-/ cathlab-team
VAS anxiety scale
Visual analog scale for children to assess how anxious they feel (0-10), higher scores represent more anxiety
Time frame: At handover of child from ward to anaesthesia-/ cathlab team
heart rate
heart rate
Time frame: At handover from ward to anaesthesia-/ cathlab team
Patient and parent reported outcome and experience measure
experience on the ward
Time frame: Between admission to the ward and handover to anaesthesia/ cathlab-team
Assessment of preoperative phase and anxiety/ wellbeing of the child by clinicians
Assessment by the team of the ward and the anaesthesia-/ cathlab-team
Time frame: From admission to the ward until sedation/ anaesthesia
Follow up
Assessment of the preoperative/ preinterventional phase by the child and/ or caregiver via telephone interview 2 weeks after surgery/ cathlab procedure
Time frame: 2 weeks after surgery / cathlab procedure
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Jun 2026, 17 months.
Of 178 non-industry observational studies under Heart Defects, Congenital, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 83. This study's 17 months is below that.
Counting every sponsor, half of 185 studies reached it within 44 months; a quarter within 17 and three quarters within 83.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Charite University, Berlin, Germany →